Craig Nash, Ph.D.
Craig Nash is a research scientist II in the Cardiovascular Disease Initiative at the Broad Institute of MIT and Harvard. He is focused on using his experience in cell biology and signaling to identify new therapeutic targets in cardiovascular disease as part of the Broad-Bayer collaboration.
Nash obtained his Ph.D. from the University of Birmingham, UK under the mentorship of Professor Steve Watson. He completed postdoctoral positions at the University of Leicester and University of Rochester, and a staff scientist position at the University of Michigan, all focusing on aspects of cardiovascular GPCR signaling.